Nowadays, the prevalence of infectious vibriosis soars due to the extensive development of marine fishery, resulting in substantial annual fish mortality. Traditionally, antibiotics have been the preferred treatment for vibriosis worldwide. However, the emergence of antibiotic resistance among Vibrios has prompted the gradual adoption of vaccine therapy. In comparison, vaccines demonstrate superior efficacy, combining efficiency, safety, and cost-effectiveness. Consequently, this paper aims to comprehensively review the current research progress concerning diverse vaccine types, including inactivated and attenuated vaccines, for the prevention and control of vibriosis, as well as offers a prospective outlook on the ongoing research and development endeavors focused on novel vaccine approaches to combat this disease.